Sustainability | July 26, 2023
Teva Pharmaceuticals engages Honeywell to help reduce carbon impact
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
The agency issued a Form 483 with 6 observations for Drug Substance, Drug Product units and Quality Control laboratories
Aurobindo will respond to the US FDA within the stipulated timelines
Good momentum in commercial CDMO business
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA
The company will submit its comprehensive response on these observations to the USFDA
Subscribe To Our Newsletter & Stay Updated
